MA53546A - Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide - Google Patents

Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide

Info

Publication number
MA53546A
MA53546A MA053546A MA53546A MA53546A MA 53546 A MA53546 A MA 53546A MA 053546 A MA053546 A MA 053546A MA 53546 A MA53546 A MA 53546A MA 53546 A MA53546 A MA 53546A
Authority
MA
Morocco
Prior art keywords
sulfamide
structured
kinase inhibitor
saline forms
novel hydrochloride
Prior art date
Application number
MA053546A
Other languages
English (en)
Inventor
David Jonaitis
Oskari Karjalainen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of MA53546A publication Critical patent/MA53546A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/04—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA053546A 2018-09-06 2019-09-05 Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide MA53546A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20185743 2018-09-06

Publications (1)

Publication Number Publication Date
MA53546A true MA53546A (fr) 2021-12-15

Family

ID=67982092

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053546A MA53546A (fr) 2018-09-06 2019-09-05 Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide

Country Status (13)

Country Link
US (1) US11866420B2 (fr)
EP (1) EP3846906A1 (fr)
JP (1) JP7528060B2 (fr)
KR (1) KR20210057759A (fr)
CN (1) CN112805065B (fr)
AU (1) AU2019334693B2 (fr)
CA (1) CA3111040A1 (fr)
EA (1) EA202190696A1 (fr)
MA (1) MA53546A (fr)
MX (1) MX2021002524A (fr)
MY (1) MY203097A (fr)
SG (1) SG11202102110PA (fr)
WO (1) WO2020049217A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110446704B (zh) * 2017-03-23 2022-07-05 奥赖恩公司 用于制备磺酰胺结构化的激酶抑制剂的方法
US20230119355A1 (en) * 2020-03-05 2023-04-20 Aurigene Discovery Technologies Limited Pharmaceutical compositions of a kinase inhibitor
WO2024218649A2 (fr) * 2023-04-17 2024-10-24 Aurigene Oncology Limited Combinaison d'un inhibiteur de protéine kinase avec des agents immunomodulateurs
WO2024246852A2 (fr) * 2023-06-01 2024-12-05 Aurigene Oncology Limited Méthode de traitement de maladies fibrotiques à l'aide d'un inhibiteur de protéine kinase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA111382C2 (uk) 2011-10-10 2016-04-25 Оріон Корпорейшн Інгібітори протеїнкінази
CN110446704B (zh) * 2017-03-23 2022-07-05 奥赖恩公司 用于制备磺酰胺结构化的激酶抑制剂的方法
WO2020135878A1 (fr) * 2018-12-29 2020-07-02 南京明德新药研发有限公司 Dérivé d'imidazopyridine utilisé en tant qu'inhibiteur double de fgfr et vegfr
WO2020249096A1 (fr) * 2019-06-14 2020-12-17 南京明德新药研发有限公司 Composé cyclique fusionné en tant qu'inhibiteur double de fgfr et vegfr

Also Published As

Publication number Publication date
KR20210057759A (ko) 2021-05-21
AU2019334693B2 (en) 2025-04-03
CA3111040A1 (fr) 2020-03-12
US20210332028A1 (en) 2021-10-28
AU2019334693A1 (en) 2021-05-13
EA202190696A1 (ru) 2021-06-16
JP2022501328A (ja) 2022-01-06
CN112805065A (zh) 2021-05-14
JP7528060B2 (ja) 2024-08-05
EP3846906A1 (fr) 2021-07-14
WO2020049217A1 (fr) 2020-03-12
SG11202102110PA (en) 2021-04-29
MX2021002524A (es) 2021-04-28
CN112805065B (zh) 2024-07-05
MY203097A (en) 2024-06-09
US11866420B2 (en) 2024-01-09

Similar Documents

Publication Publication Date Title
MA54526A (fr) NOUVELLES FORMES POLYMORPHES D'UN INHIBITEUR DE TGFBeta
MA54458A (fr) Formes cristallines et formes salines d'un inhibiteur de kinase
EP3976624A4 (fr) Inhibiteur de protéine kinase dépendante de l'adn
EP4267598A4 (fr) Nouvelles protéines inhibitrices d'insectes
EP4104000A4 (fr) Pont d'outil
EP3532240A4 (fr) Base d'outillage
EP3782084A4 (fr) Activation d'une capture vocale intra-auriculaire à l'aide d'un apprentissage profond
EP4000258A4 (fr) Mise à l'échelle de coefficients à base de position
EP3995553A4 (fr) Adhésif à base d'isocyanate
EP3500286A4 (fr) Synthèse d'échelle d'elamipretide à base de n-carboxyanhydride
EP4373420A4 (fr) Vis à os
MA55801A (fr) Formes solides d'un inhibiteur de glyt1
EP4264309A4 (fr) Positionnement d'empreintes digitales amélioré
EP3787641A4 (fr) Nettoyants de paupière à base d'acide hypochloreux
EP3909068A4 (fr) Inhibiteur de corrosion à base d'oxyde de hafnium
EP3885377A4 (fr) Polymère à base d'oléfine
EP4021442A4 (fr) Inhibiteurs conjugués de la réponse à l'endommagement de l'adn
MA47203A (fr) Inhibiteurs d'antiport à médiation par nhe
EP3897660A4 (fr) Nouvelles formes cristallines d'un composé de nrtti
EP3957660A4 (fr) Polymère à base d'oléfine
EP3917319A4 (fr) Herbicides à base d'acétamide microencapsulé
EP3956358A4 (fr) Polythérapie à base d'inhibiteur d'alpha4bêta7 et d'inhibiteur d'il-23
SG11202102110PA (en) Novel hydrochloride salt forms of a sulfonamide structured kinase inhibitor
EP4005087A4 (fr) Fonctionnements à l'épreuve des pannes d'une machine hexaphasée
EP3750064A4 (fr) Opérations de sauvegarde d'une mémoire volatile à une mémoire non volatile